أعرض في EDS

1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

التفاصيل البيبلوغرافية
العنوان: 1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION
المؤلفون: H.A. Tatum, E.J. Lawitz, Reem Ghalib, J. Zamparo, Paul J. Thuluvath, M. Demicco, Rong Yang, Natarajan Ravendhran, J. Hanson, Vinod K. Rustgi, S. Cohen, Claudia Martorell, E. Cooney, Eric Hughes
المصدر: Journal of Hepatology. 56:S460
بيانات النشر: Elsevier BV, 2012.
سنة النشر: 2012
مصطلحات موضوعية: medicine.medical_specialty, Hepatology, business.industry, Ribavirin, Gastroenterology, Ns5b polymerase, Therapy naive, chemistry.chemical_compound, chemistry, Chronic hepatitis, Internal medicine, Genotype, Medicine, business, Peginterferon alfa-2a, medicine.drug
تدمد: 0168-8278
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e54fbb55ced4e490a8f64d726be525a9
https://doi.org/10.1016/s0168-8278(12)61175-1
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........e54fbb55ced4e490a8f64d726be525a9
قاعدة البيانات: OpenAIRE
الوصف
تدمد:01688278